Navigation Links
10 years of health innovation in Africa
Date:6/5/2013

re needed to support this strategy.

DNDi and a number of other new partnership initiatives set up during the last decade are bringing together the public and private sectors, in collaboration with WHO, TDR, and others to develop such new health tools. While not the ultimate solution to R&D gaps, these new models contribute significantly to the fight against neglected diseases.

'DNDi has developed six new treatments for four neglected diseases in the past decade, but there are still other neglected diseases that continue to lack good treatment options. While this progress is a good start, the treatments delivered are far from optimal. We have not yet developed new modern drugs which could change the history of certain neglected diseases,' said Dr Bernard Pcoul, Executive Director of DNDi. 'To truly fight neglect, we must push for more innovation and access of new treatments together with adequate coordination with control programmes. Progress to date shows this can be done in and with countries in Africa.'

DNDi and partners in Africa have established two regional R&D disease networks: the Leishmaniasis East Africa Platform (LEAP), launched in 2003 in Khartoum, Sudan; and the Human African Trypanosomiasis (HAT) Platform, launched in 2005 in Kinshasa, Democratic Republic of the Congo. LEAP was instrumental in the development of the combination drug SSG&PM (sodium stibogluconate and paromomycin) for the treatment of visceral leishmaniasis (kala azar) in East Africa, while the HAT Platform played a major role in the development of NECT (nifurtimox-eflornithine combination therapy) for the treatment of late-stage sleeping sickness.

'Around the world we are moving ahead in leaps and bounds, as ten years ago, good clinical practice was not the norm. Africa has moved very quickly in in this field and in the regulatory area and in ethics review. We need very strong clinical and regulatory practice to do good R&D,' said Dr Charles Mgone, E
'/>"/>

Contact: Violaine Dällenbach
vdallenbach@dndi.org
41-794-241-474
Drugs for Neglected Diseases Initiative
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Goldlite Hypnosis Institute Helped Maria Stop Compulsive Skin Picking and Nail Biting after doing it for 25 years.
2. Advanced Heart Failure Still Kills 1 in 3 Within Three Years: Study
3. Automated Security Alert's New Technology Provides Years Of Independence
4. Ezell Law Firm Celebrates 25 Years in Practice
5. A pan-European study: Signs of motor disorders can appear years before disease manifestation
6. Taking Actos for Two Years Caused Bladder Cancer, Alleges Lawsuit Filed by Parker Waichman LLP on Behalf of South Dakota Man
7. Palm Springs Tramway Celebrates 50 Years While Palm Springs Real Estate Sizzles by Brad Schmett
8. Standing With Hope's New Website Utilizes the Experience of its Founder's 27 Years as a Caregiving Husband - to Offer Practical Help and Wisdom to Today's Caregivers
9. Recent Release of ‘The Narconon Program - 40 Years of Evidence of Recovery’ Reveals Earlier Unfound Narconon Connecticut Study
10. Best Rated Cosmetic Dermatologist – Patient’s Choice Award Winner 3 Years in a Row
11. Missouri Man Alleges Five Years of Actos Use Caused his Bladder Cancer; Parker Waichman LLP Files Lawsuit on Victim’s Behalf
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Savannah, GA (PRWEB) September 18, 2014 ... awarded the Alex Ormond, Jr. Leadership Award by the ... toward improving healthcare and wellness throughout the nation and ... to receive this award,” said Ben. “The Savannah Science ... for 65 years and multiple generations have gone through ...
(Date:9/18/2014)... will convene a one-day conference at the Milken Institute ... on September 25, 2014 to discuss the Global Health ... The purpose of this event is to invite discussion ... five years, including action plans to curtail the current ... the GHSA, international organizations and more than 50 countries ...
(Date:9/18/2014)... the Ebola virus invoke scary scenarios of deadly epidemics, ... are still providing researchers with new insights on how ... published online Sept. 18, 2014, in the journal ... Medical School Singapore detail how the Yersinia pestis bacteria ... the lymph nodes and eventually ride into the lungs ...
(Date:9/18/2014)... 18, 2014 As testosterone treatment ... U.S. courts, Bernstein Liebhard LLP notes that a ... Food & Drug Administration (FDA) subject prescription low ... could greatly reduce their use. The joint meeting ... Advisory Committee, and the Drug Safety and Risk ...
(Date:9/18/2014)... Once again, Hickman’s Family Farms will partner with ... to celebrate PJs & Eggs. The sixth annual event ... 10, 2014. The “breakfast for dinner” will begin at ... Association (AzCA) foster care programs statewide. , Customers ... on October 10 are invited to wear their pajamas ...
Breaking Medicine News(10 mins):Health News:Quirk Awarded the Alex Ormond, Jr. Leadership Award by the Savannah Science Seminar 2Health News:Non-governmental stakeholders to discuss the Global Health Security Agenda 2Health News:New insights on an ancient plague could improve treatments for infections 2Health News:Testosterone Treatment News: Bernstein Liebhard LLP Notes Experts’ Recommendations for New Restrictions on Low Testosterone Therapy 2Health News:Testosterone Treatment News: Bernstein Liebhard LLP Notes Experts’ Recommendations for New Restrictions on Low Testosterone Therapy 3Health News:Testosterone Treatment News: Bernstein Liebhard LLP Notes Experts’ Recommendations for New Restrictions on Low Testosterone Therapy 4Health News:October 10th Is 6th Annual PJs & Eggs: Hickman’s Family Farms and Breakfast Restaurants Partner to Benefit Arizona Foster Children 2
... Mann HealthDay Reporter , THURSDAY, Feb. 16 (HealthDay ... be a hidden source of arsenic, new research suggests. ... brown rice syrup, is found in some infant formulas. Their ... Health Perspectives . Arsenic is a natural element that ...
... delivery directly into muscle using an autoinjector is faster ... according to a study sponsored by the National Institutes ... School of Medicine researcher. The trial compared the ... how they are administered to patients suffering prolonged seizures ...
... , THURSDAY, Feb. 16 (HealthDay News) -- Doing ... that all Americans must have health insurance would not ... insurance exchanges, but would significantly reduce the number of ... findings from the RAND Corporation, a nonprofit research organization, ...
... Mann HealthDay Reporter , WEDNESDAY, Feb. 15 ... help problem drinkers cut their alcohol consumption, a small ... curbs drinking is not fully understood, but its use ... sadness and nausea, thereby blunting the pleasurable effects of ...
... Reporter , WEDNESDAY, Feb. 15 (HealthDay News) -- Researchers report ... kicking off puberty in humans, a finding that offers insight ... who suffer from a rare disease that prevents the start ... family whose members have suffered from the disease confirmed that ...
... Feb. 15 (HealthDay News) -- How fast you walk or how ... odds for dementia or stroke later in life, a new study ... performed in a doctor,s office, noted study author Dr. Erica C. ... tested the walking speed, hand grip strength and cognitive function of ...
Cached Medicine News:Health News:Arsenic Might Be Found in Some Organic Foods: Study 2Health News:Arsenic Might Be Found in Some Organic Foods: Study 3Health News:Wayne State research reveals improved method for paramedics to stop prolonged seizures 2Health News:Wayne State research reveals improved method for paramedics to stop prolonged seizures 3Health News:Wayne State research reveals improved method for paramedics to stop prolonged seizures 4Health News:Health Insurance 'Mandate' Deemed Best Value for Money 2Health News:Stop-Smoking Drug May Also Curb Problem Drinking 2Health News:Gene Linked to Start of Puberty 2Health News:Can Walking Speed, Hand Grip in Middle Age Predict Dementia Risk? 2
(Date:9/18/2014)... 18, 2014 Research and Markets ... Balloon Market Investment Report, 2014-2016" report to their ... medical device in percutaneous coronary intervention (PCI), serves not ... as a device for pre-/post-stent dilatations. Therefore, the development ... of PCI. As national economy develops and ...
(Date:9/18/2014)... LONDON , Sept. 18, 2014 ... companies. Competition for innovation, increasing clinical development costs, ... with the fast-changing environment are important factors driving ... and clinical trial costs continue to rise due ... Studies conducted by industry think tanks suggest ...
(Date:9/18/2014)... 2014  KIYATEC announced today that it has ... Research (SBIR) Phase II Contract from the National ... and centers that comprise the National Institutes of ... year award, KIYATEC will expand its 3D breast ... forefront of cancer therapy strategies: 1) cancer,s interaction ...
Breaking Medicine Technology:China PTCA Balloon Market Investment Report, 2014-2016 2China PTCA Balloon Market Investment Report, 2014-2016 3Patient Recruitment in Asia Biotech and Pharma Companies 2Patient Recruitment in Asia Biotech and Pharma Companies 3National Cancer Institute Awards KIYATEC Nearly $2M to Advance Predictive Cancer Diagnostics 2National Cancer Institute Awards KIYATEC Nearly $2M to Advance Predictive Cancer Diagnostics 3
... (NASDAQ: OPTR ) today announced the presentation ... (DDW) conference highlighting additional analyses of data from Phase ... the treatment of Clostridium difficile infection (CDI). ... first analysis aimed to identify risk factors associated with ...
... MINNEAPOLIS, May 9, 2011 BioDrain Medical, Inc. (OTC ... FDA-cleared Streamway™ System for automated surgical fluid disposal, announced ... ("EKN"), a New York-based registered broker/dealer, as its exclusive ... terms of the agreement, EKN will assist the Company ...
Cached Medicine Technology:Data Presented at Digestive Disease Week Highlights Additional Analysis of DIFICID™ Phase 3 Data 2Data Presented at Digestive Disease Week Highlights Additional Analysis of DIFICID™ Phase 3 Data 3Data Presented at Digestive Disease Week Highlights Additional Analysis of DIFICID™ Phase 3 Data 4BioDrain Medical, Inc. Retains EKN Financial Services as Its Exclusive Financial Advisor and Placement Agent 2BioDrain Medical, Inc. Retains EKN Financial Services as Its Exclusive Financial Advisor and Placement Agent 3
... Ad-Techs Foramen Ovale Electrodes provide you ... These electrodes offer the same proven design ... that they are placed using an introducing ... a smaller electrode body diameter, 3 to ...
... The Small Joint Ball Electrode ... in small joint applications. With its ... tip, controlled capsuloligamentous or tendinous tissue ... When used in conjunction with the ...
... is designed to replace the carpal scaphoid bone. ... pole which fits under a shelf formed in ... suture hole on the proximal hole for suture ... the early postoperative period until a firm capsuloligamentous ...
... two-piece Titanium (Ti-6Al-4V) screw offered in two ... of lengths. The two pieces are loaded ... A single instrument set contains all items ... Standard and Mini Kompressor Compression Screws. , ...
Medicine Products: